FDA Approves Triple Drug Combo for Melanoma FDA Approves Triple Drug Combo for Melanoma

The triple-therapy combination of atezolizumab plus cobimetinib and vemurafenib is now approved for BRAF V600mutation-positive advanced melanoma.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news